Tag: medication

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

ENERGY DRINKS AND THE PROTECTION OF YOUTH: ROSEMÈRE TAKES ACTION

ROSEMÈRE, QC, June 2, 2026 /CNW/ - The Rosemère Town Council unanimously adopted a resolution in support of the Zachary Miron Movement, founded by...

HelloNation Article Explains Protecting Eyes From Kentucky Allergies Featuring Optometry Expert Dr. Kimberly Arnett

The article clarifies how to distinguish allergy symptoms from infections and outlines steps to reduce irritation and protect eye health.FLORENCE, Ky., June 2, 2026...

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

NEWARK, Del., June 2, 2026 /PRNewswire/ -- The Demand for Compounding Pharmacies in USA is projected to grow from USD 6.04 billion in 2026 to...

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

AddiVance Offers Families a Drug-Free Option for Daily Focus, Attention, and Cognitive Support

AddiVance is formulated to support focus, attention, mood balance, and everyday cognitive performance as part of a healthy lifestyleWEST CHESTER, Ohio, June 1, 2026...

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Young Mother’s Battle with Arthritis Highlights Need for Timely Access to Modern Medications in BC

VANCOUVER, BC, Aug. 14, 2025 /CNW/ - Eileen Davidson, a Burnaby mother and advocate, is calling on the BC government to modernize its approach to...

On Demand Pharmaceuticals Welcomes HHS Leadership to Showcase Breakthrough Domestic Pharmaceutical Manufacturing Capabilities

ROCKVILLE, Md., Aug. 14, 2025 /PRNewswire/ -- Today, On Demand Pharmaceuticals (ODP) hosted senior officials from the U.S. Department of Health and Human Services...

Vertigenics – The Natural Vertigo Breakthrough Driving 2025 Interest in Balance and Brain Support Formulas

Public Interest in Natural Vertigo Support and Ingredient-First Balance Formulas Continues to Rise in 2025

Public Interest in Natural Vertigo Support and Ingredient-First Balance Formulas Continues to Rise in 2025

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsMedication

Decisions taken by Suominen Corporation’s Extraordinary General Meeting

Værdipapirfonden Sydinvest ajourført prospekt

Lumissil Introduces a High-Voltage, Dual-Channel LED Lighting Controller for 48V Automotive Systems

Tag: medication

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

ENERGY DRINKS AND THE PROTECTION OF YOUTH: ROSEMÈRE TAKES ACTION

HelloNation Article Explains Protecting Eyes From Kentucky Allergies Featuring Optometry Expert Dr. Kimberly Arnett

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Ping An Launches “Ping An Home” Service Brand

Ping An Launches “Ping An Home” Service Brand

AddiVance Offers Families a Drug-Free Option for Daily Focus, Attention, and Cognitive Support

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Young Mother’s Battle with Arthritis Highlights Need for Timely Access to Modern Medications in BC

On Demand Pharmaceuticals Welcomes HHS Leadership to Showcase Breakthrough Domestic Pharmaceutical Manufacturing Capabilities

Vertigenics – The Natural Vertigo Breakthrough Driving 2025 Interest in Balance and Brain Support Formulas

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us